NCT01386606View on ClinicalTrials.gov

The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Secondary Hypogonadism
Interventions
DRUG

Androxal (enclomiphene citrate)

"capsule oral~1X a day 6 weeks"

DRUG

Testosterone

"topical gel~1X a day 6 weeks"

Trial Locations (2)

77062

Centex Research, Houston

78229

Cetero Research, San Antonio

All Listed Sponsors
lead

Repros Therapeutics Inc.

INDUSTRY

NCT01386606 - The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) | Biotech Hunter | Biotech Hunter